Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ TAMSULOSIN CR SANDOZ CANADA INCORPORATED Anticipated shortage 0.4MG Updated Report 2024-05-21 228446
SANDOZ TAMSULOSIN CR SANDOZ CANADA INCORPORATED Anticipated shortage 0.4MG Updated Report 2024-05-21 228441
MULTI 12 INJECTION SANDOZ CANADA INCORPORATED Actual shortage 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG Updated Report 2024-05-21 217399
SANDOZ TOLTERODINE LA SANDOZ CANADA INCORPORATED Anticipated shortage 4MG New Report 2024-05-21 228430
SANDOZ SOLIFENACIN SANDOZ CANADA INCORPORATED Anticipated shortage 5MG New Report 2024-05-21 228426
SANDOZ SITAGLIPTIN-METFORMIN XR SANDOZ CANADA INCORPORATED Anticipated shortage 1000MG 100MG New Report 2024-05-21 228423
SANDOZ ROSUVASTATIN SANDOZ CANADA INCORPORATED Anticipated shortage 10MG New Report 2024-05-21 228419
SANDOZ ATORVASTATIN SANDOZ CANADA INCORPORATED Anticipated shortage 40MG New Report 2024-05-21 228415
FLAGYL SANOFI-AVENTIS CANADA INC Actual shortage 10% Updated Report 2024-05-21 215793
SANDOZ LACOSAMIDE SANDOZ CANADA INCORPORATED Actual shortage 100MG Updated Report 2024-05-21 225218

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-18 228249
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-05-18 228256
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 40MG Updated Report 2024-05-18 228263
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Discontinued 50MG 8.6MG Updated Report 2024-05-18 228268
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166